JP6407151B2 - アザイサト酸無水物又はその誘導体の一つを用いた官能化の方法及びこの方法において使用される試薬、このように処置された生物学的分子及びキット - Google Patents

アザイサト酸無水物又はその誘導体の一つを用いた官能化の方法及びこの方法において使用される試薬、このように処置された生物学的分子及びキット Download PDF

Info

Publication number
JP6407151B2
JP6407151B2 JP2015524746A JP2015524746A JP6407151B2 JP 6407151 B2 JP6407151 B2 JP 6407151B2 JP 2015524746 A JP2015524746 A JP 2015524746A JP 2015524746 A JP2015524746 A JP 2015524746A JP 6407151 B2 JP6407151 B2 JP 6407151B2
Authority
JP
Japan
Prior art keywords
rna
group
interest
molecule
binding molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2015524746A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015526076A (ja
JP2015526076A5 (https=
Inventor
トマ カイイ，
トマ カイイ，
フレデリク ファビズ，
フレデリク ファビズ，
アリ ラアユーン，
アリ ラアユーン，
アラン ローラン，
アラン ローラン，
シルヴァン ユールスーギー，
シルヴァン ユールスーギー，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA filed Critical Biomerieux SA
Publication of JP2015526076A publication Critical patent/JP2015526076A/ja
Publication of JP2015526076A5 publication Critical patent/JP2015526076A5/ja
Application granted granted Critical
Publication of JP6407151B2 publication Critical patent/JP6407151B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/6825—Nucleic acid detection involving sensors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2015524746A 2012-08-02 2013-07-26 アザイサト酸無水物又はその誘導体の一つを用いた官能化の方法及びこの方法において使用される試薬、このように処置された生物学的分子及びキット Expired - Fee Related JP6407151B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1257526 2012-08-02
FR1257526A FR2994184B1 (fr) 2012-08-02 2012-08-02 Procedes de fonctionalisation et reactifs utilises dans de tels procedes utilisant un anhydride aza-isatoique ou un de ses derives, molecules biologiques ainsi traitees et kits
PCT/EP2013/065854 WO2014019966A1 (fr) 2012-08-02 2013-07-26 Procedes de fonctionnalisation et reactifs utilises dans de tels procedes utilisant un anhydride aza-isatoïque ou un de ses derives, molecules biologiques ainsi traitees et kits

Publications (3)

Publication Number Publication Date
JP2015526076A JP2015526076A (ja) 2015-09-10
JP2015526076A5 JP2015526076A5 (https=) 2017-12-21
JP6407151B2 true JP6407151B2 (ja) 2018-10-17

Family

ID=46963941

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015524746A Expired - Fee Related JP6407151B2 (ja) 2012-08-02 2013-07-26 アザイサト酸無水物又はその誘導体の一つを用いた官能化の方法及びこの方法において使用される試薬、このように処置された生物学的分子及びキット

Country Status (5)

Country Link
US (2) US10174068B2 (https=)
EP (1) EP2880016A1 (https=)
JP (1) JP6407151B2 (https=)
FR (1) FR2994184B1 (https=)
WO (1) WO2014019966A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3053968A1 (fr) * 2016-07-13 2018-01-19 Biomerieux Reactifs pour la protection reversible de molecules biologiques
RU2020112854A (ru) 2017-11-30 2021-12-30 Арракис Терапьютикс, Инк. Фотозонды, связывающие нуклеиновые кислоты, и способы их применения
CN111913028A (zh) * 2020-08-18 2020-11-10 宁波中车时代传感技术有限公司 基于芯片型线圈的磁通门电流传感器

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1060102A (fr) 1951-12-08 1954-03-30 Sawyer S Inc Support de vues stéréoscopiques dispositives et son procédé de labrication
US3838120A (en) * 1972-12-07 1974-09-24 Sterling Drug Inc 1-alkyl-1h,4h-pyrido(2,3-d)(1,3)oxazine-2,4-diones and their conversion to 1-alkyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids
US4711955A (en) 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
EP0329198B1 (en) 1981-04-17 1998-06-10 Yale University Base modified oligo- and polynucleotides and methods of preparing and using same
CA1219824A (en) 1981-04-17 1987-03-31 David C. Ward Modified nucleotides and methods of preparing and using same
CA1223831A (en) 1982-06-23 1987-07-07 Dean Engelhardt Modified nucleotides, methods of preparing and utilizing and compositions containing the same
DE3910151A1 (de) 1989-03-29 1990-10-04 Toni Dr Lindl 5'-bromo-2'-desoxyuridinmarkierte dna- oder rna- sonden
CA2129105A1 (en) 1992-02-12 1993-08-19 Michael J. Conrad Applications of fluorescent n-nucleosides and fluorescent structural analogs of n-nucleosides
DE4213703A1 (de) 1992-04-25 1993-10-28 Merck Patent Gmbh Fluoreszenzmarkierte Verbindungen, ihre Herstellung und Verwendung
US6027945A (en) 1997-01-21 2000-02-22 Promega Corporation Methods of isolating biological target materials using silica magnetic particles
AU4588000A (en) 1999-04-30 2000-12-28 Cyclops Genome Sciences Limited Polynucleotides
DE60137203D1 (de) 2000-03-24 2009-02-12 Qiagen Gmbh Poröse ferro- oder ferrimagnetische glasteilchen für molekültrennung
GB0024807D0 (en) 2000-10-10 2000-11-22 Smithkline Beecham Plc Novel compounds
FR2824323B1 (fr) 2001-05-04 2008-04-25 Bio Merieux Reactif de marquage et procede de detection de molecules biologiques
AU2002359522A1 (en) 2001-11-28 2003-06-10 Applera Corporation Compositions and methods of selective nucleic acid isolation
SE0200543D0 (sv) 2002-02-21 2002-02-21 Amersham Biosciences Ab Method of separation using aromatic thioether ligands
GB0217963D0 (en) 2002-08-02 2002-09-11 Cyclops Genome Sciences Ltd Purification of nucleic acids
US7902203B2 (en) * 2002-11-01 2011-03-08 Abbott Laboratories, Inc. Anti-infective agents
ES2391770T3 (es) * 2003-01-21 2012-11-29 Novartis Vaccines And Diagnostics, Inc. Uso de compuestos de triptantrina para la potenciación inmune
JP4241183B2 (ja) 2003-05-19 2009-03-18 株式会社日立ハイテクノロジーズ 核酸回収方法及び核酸回収キット
EP1510577A1 (en) 2003-08-29 2005-03-02 Qiagen GmbH Method for magnetic bead isolation of nucleic acids
US20050106577A1 (en) 2003-11-17 2005-05-19 Hashem Akhavan-Tafti Cleavable solid phases for isolating nucleic acids
US20050106576A1 (en) 2003-11-17 2005-05-19 Hashem Akhavan-Tafti Methods of using cleavable solid phases for isolating nucleic acids
DE10358137A1 (de) 2003-12-12 2005-07-07 Merck Patent Gmbh Verfahren und Kit zur Isolierung von RNA
FR2868071B1 (fr) 2004-03-26 2006-06-09 Biomerieux Sa Reactifs de marquage, procedes de synthese de tels reactifs et procedes de detection de molecules biologiques
US20050239091A1 (en) 2004-04-23 2005-10-27 Collis Matthew P Extraction of nucleic acids using small diameter magnetically-responsive particles
DE102004034433A1 (de) 2004-07-15 2006-02-02 Qiagen Gmbh Verfahren zur Reinigung und Isolierung von Nukleinsäuren unter Verwendung kationischer Detergentien
DE102005015005A1 (de) 2005-04-01 2006-10-05 Qiagen Gmbh Verfahren zur Behandlung einer Biomoleküle enthaltenden Probe
US7569367B2 (en) 2005-09-07 2009-08-04 Roche Diagnostics Operations, Inc. Nucleic acid preparation from whole blood for use in diagnosis of transmissible spongiform encephalopathy
WO2007145940A2 (en) * 2006-06-05 2007-12-21 The University Of North Carolina At Chapel Hill High-throughput rna structure analysis
EP2142509B1 (en) 2007-04-18 2013-12-04 Amgen, Inc Quinolones and azaquinolones that inhibit prolyl hydroxylase
FR2917090B1 (fr) 2007-06-11 2012-06-15 Biomerieux Sa Reactifs de marquage portant des fonctions diazo et nitro, procedes de synthese de tels reactifs et procedes de detection de molecules biologiques
GB0719022D0 (en) 2007-09-28 2007-11-07 Mole Genetics As Isolation method
FR2934595B1 (fr) 2008-07-29 2013-04-05 Biomerieux Sa Reactifs de marquage ayant un noyau pyridine portant une fonction diazomethyle, procedes de synthese de tels reactifs et procedes de detection de molecules biologiques
EP2491030B1 (en) * 2009-10-22 2015-07-15 Fibrotech Therapeutics PTY LTD Fused ring analogues of anti-fibrotic agents
FR2968302B1 (fr) * 2010-12-06 2012-11-30 Biomerieux Sa Procedes de fonctionalisation et reactifs utilises dans de tels procedes utilisant un anhydride isatoique ou un de ses derives, molecules biologiques ainsi traitees et kits

Also Published As

Publication number Publication date
FR2994184A1 (fr) 2014-02-07
US20150210732A1 (en) 2015-07-30
FR2994184B1 (fr) 2017-12-08
WO2014019966A1 (fr) 2014-02-06
US20190112329A1 (en) 2019-04-18
JP2015526076A (ja) 2015-09-10
US10174068B2 (en) 2019-01-08
EP2880016A1 (fr) 2015-06-10

Similar Documents

Publication Publication Date Title
ES2640279T3 (es) Procedimiento para la síntesis de un complejo bifuncional
JP2797047B2 (ja) 受身固定により核酸フラグメントを固体支持体上に不動化する方法、そのようにして得られた固体支持体およびその使用
AU2003214031A1 (en) An improved method for synthesising templated molecules
CN100509761C (zh) 标记试剂,合成该试剂的方法以及检测生物分子的方法
KR20010089276A (ko) 패러렐 셀렉스
US20190112329A1 (en) Methods of functionalization and reagents used in such methods using an aza-isatoic anhydride or a derivative thereof, biological molecules thus treated and kits
EP1140963B1 (fr) Compose fonctionnalise, polynucleotide eventuellement marque et procede de detection d'un acide nucleique cible
JP2014504282A (ja) イサト酸無水物またはその誘導体を用いる官能化法およびこのような方法に用いる試薬、こうして処理された生体分子およびキット
JP2015526076A5 (https=)
US20060292586A1 (en) ID-tag complexes, arrays, and methods of use thereof
US8426127B2 (en) Fluorescence-producing molecule
JP2023506891A (ja) 連続的な標識スキームを使用した合成による配列決定方法
Schlatterer et al. Universal initiator nucleotides for the enzymatic synthesis of 5′-amino-and 5′-thiol-modified RNA
JP2000316587A (ja) 核酸プローブ
WO2023034969A1 (en) Hybridization probes containing fluorinated carbon chains and related methods
Kore Solid-phase synthesis of new ribo and deoxyribo BrdU probes for labeling and detection of nucleic acids
JP4738741B2 (ja) テンプレートされた分子を合成するための改良法
ES2837117T3 (es) Codificación enzimática
Nadal et al. Aptamers for Analysis: Nucleic Acids Ligands in the Post‐Genomic Era
JP2005521365A6 (ja) テンプレートされた分子を合成するための改良法
Ryan Design and synthesis of probes for detection of protein-protein interaction and RNA localization
Rao Synthesis and enzymatic incorporation of an azide-modified uridine triphosphate analogue
VERMA et al. Applications of Ribonucleotide Analogues in RNA Biochemistry

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150611

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160512

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170509

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170726

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20171006

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20171109

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180327

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180726

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20180806

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180821

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180918

R150 Certificate of patent or registration of utility model

Ref document number: 6407151

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees